Logos Global Management as of March 31, 2024
Portfolio Holdings for Logos Global Management
Logos Global Management holds 53 positions in its portfolio as reported in the March 2024 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Sarepta Therapeutics (SRPT) | 16.8 | $207M | 1.6M | 129.46 | |
| Alnylam Pharmaceuticals Call Option (ALNY) | 6.0 | $75M | 500k | 149.45 | |
| Ideaya Biosciences (IDYA) | 5.3 | $66M | 1.5M | 43.88 | |
| Immunocore Hldgs Ads (IMCR) | 4.7 | $59M | 900k | 65.00 | |
| Immunovant (IMVT) | 4.6 | $57M | 1.8M | 32.31 | |
| Ocular Therapeutix (OCUL) | 4.2 | $52M | 5.8M | 8.95 | |
| Structure Therapeutics Sponsored Ads (GPCR) | 4.1 | $50M | 1.2M | 42.86 | |
| Olema Pharmaceuticals (OLMA) | 4.0 | $50M | 4.4M | 11.32 | |
| Dyne Therapeutics (DYN) | 4.0 | $49M | 1.7M | 28.39 | |
| Apellis Pharmaceuticals (APLS) | 3.8 | $47M | 800k | 58.78 | |
| Rocket Pharmaceuticals (RCKT) | 2.8 | $35M | 1.3M | 26.94 | |
| Astria Therapeutics Call Option (ATXS) | 2.6 | $32M | 2.2M | 14.07 | |
| Silence Therapeutics Ads (SLN) | 2.5 | $31M | 1.5M | 21.06 | |
| Geron Corporation (GERN) | 2.4 | $30M | 9.0M | 3.30 | |
| Annexon (ANNX) | 2.4 | $29M | 4.1M | 7.17 | |
| Celldex Therapeutics Com New (CLDX) | 2.2 | $27M | 650k | 41.97 | |
| Enliven Therapeutics (ELVN) | 2.1 | $26M | 1.6M | 16.78 | |
| Vera Therapeutics Cl A (VERA) | 2.0 | $25M | 575k | 43.12 | |
| Adverum Biotechnologies Com New (ADVM) | 1.7 | $21M | 1.5M | 14.14 | |
| Design Therapeutics (DSGN) | 1.6 | $20M | 5.0M | 4.03 | |
| Akero Therapeutics (AKRO) | 1.6 | $20M | 800k | 25.26 | |
| Cybin Ord | 1.3 | $17M | 40M | 0.41 | |
| Xencor (XNCR) | 1.2 | $14M | 650k | 22.13 | |
| Cg Oncology (CGON) | 1.1 | $13M | 300k | 43.90 | |
| Engene Holdings (ENGN) | 1.0 | $13M | 800k | 16.10 | |
| Kyverna Therapeutics (KYTX) | 1.0 | $12M | 500k | 24.84 | |
| Miragen Therapeutics (VRDN) | 1.0 | $12M | 700k | 17.51 | |
| Cullinan Oncology (CGEM) | 1.0 | $12M | 700k | 17.04 | |
| Immatics SHS (IMTX) | 0.9 | $11M | 1.0M | 10.51 | |
| Spyre Therapeutics Com New (SYRE) | 0.8 | $9.5M | 250k | 37.93 | |
| Fulcrum Therapeutics Call Option (FULC) | 0.8 | $9.4M | 1.0M | 9.44 | |
| Lineage Cell Therapeutics In (LCTX) | 0.7 | $9.3M | 6.3M | 1.48 | |
| Praxis Precision Medicines I Com New (PRAX) | 0.7 | $9.2M | 150k | 61.02 | |
| Applied Therapeutics (APLT) | 0.7 | $9.0M | 1.4M | 6.65 | |
| Syndax Pharmaceuticals (SNDX) | 0.7 | $8.3M | 350k | 23.80 | |
| Trevi Therapeutics (TRVI) | 0.6 | $7.6M | 2.2M | 3.45 | |
| Cytokinetics Com New (CYTK) | 0.6 | $7.0M | 100k | 70.11 | |
| Kura Oncology (KURA) | 0.5 | $6.4M | 300k | 21.33 | |
| Neumora Therapeutics (NMRA) | 0.5 | $6.2M | 382k | 16.20 | |
| Atyr Pharma Com New (ATYR) | 0.5 | $6.0M | 3.1M | 1.95 | |
| Janux Therapeutics (JANX) | 0.5 | $5.6M | 150k | 37.65 | |
| Larimar Therapeutics Call Option (LRMR) | 0.4 | $5.3M | 700k | 7.59 | |
| Elevation Oncology (ELEV) | 0.4 | $5.1M | 1.0M | 5.13 | |
| Nextcure (NXTC) | 0.3 | $4.3M | 1.9M | 2.23 | |
| Allakos (ALLK) | 0.3 | $3.7M | 2.9M | 1.26 | |
| Unicycive Therapeutics (UNCY) | 0.2 | $3.0M | 3.5M | 0.87 | |
| Boundless Bio (BOLD) | 0.2 | $2.9M | 200k | 14.25 | |
| Tourmaline Bio (TRML) | 0.2 | $2.3M | 99k | 22.90 | |
| Compass Pathways Sponsored Ads (CMPS) | 0.1 | $1.8M | 258k | 7.03 | |
| Io Biotech (IOBT) | 0.1 | $854k | 494k | 1.73 | |
| Immunic (IMUX) | 0.0 | $556k | 421k | 1.32 | |
| Leap Therapeutics Com New (LPTX) | 0.0 | $105k | 40k | 2.66 | |
| Nuvation Bio *w Exp 07/07/202 (NUVB.WS) | 0.0 | $23k | 67k | 0.34 |
